Correlation Between Eventide Healthcare and Eventide Multi-asset

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eventide Healthcare and Eventide Multi-asset at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eventide Healthcare and Eventide Multi-asset into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eventide Healthcare Life and Eventide Multi Asset Income, you can compare the effects of market volatilities on Eventide Healthcare and Eventide Multi-asset and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eventide Healthcare with a short position of Eventide Multi-asset. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eventide Healthcare and Eventide Multi-asset.

Diversification Opportunities for Eventide Healthcare and Eventide Multi-asset

-0.2
  Correlation Coefficient

Good diversification

The 3 months correlation between Eventide and Eventide is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Eventide Healthcare Life and Eventide Multi Asset Income in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eventide Multi Asset and Eventide Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eventide Healthcare Life are associated (or correlated) with Eventide Multi-asset. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eventide Multi Asset has no effect on the direction of Eventide Healthcare i.e., Eventide Healthcare and Eventide Multi-asset go up and down completely randomly.

Pair Corralation between Eventide Healthcare and Eventide Multi-asset

Assuming the 90 days horizon Eventide Healthcare is expected to generate 1.16 times less return on investment than Eventide Multi-asset. In addition to that, Eventide Healthcare is 2.8 times more volatile than Eventide Multi Asset Income. It trades about 0.05 of its total potential returns per unit of risk. Eventide Multi Asset Income is currently generating about 0.15 per unit of volatility. If you would invest  1,360  in Eventide Multi Asset Income on August 29, 2024 and sell it today you would earn a total of  143.00  from holding Eventide Multi Asset Income or generate 10.51% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Eventide Healthcare Life  vs.  Eventide Multi Asset Income

 Performance 
       Timeline  
Eventide Healthcare Life 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eventide Healthcare Life has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong technical indicators, Eventide Healthcare is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Eventide Multi Asset 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Eventide Multi Asset Income are ranked lower than 14 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong primary indicators, Eventide Multi-asset is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Eventide Healthcare and Eventide Multi-asset Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eventide Healthcare and Eventide Multi-asset

The main advantage of trading using opposite Eventide Healthcare and Eventide Multi-asset positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eventide Healthcare position performs unexpectedly, Eventide Multi-asset can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eventide Multi-asset will offset losses from the drop in Eventide Multi-asset's long position.
The idea behind Eventide Healthcare Life and Eventide Multi Asset Income pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies